← Back to Screener
Legend Biotech Corporation American Depositary Shares (LEGN)
Price$25.07
Favorite Metrics
Price vs S&P 500 (26W)-41.96%
Price vs S&P 500 (4W)12.10%
Market Capitalization$3.92B
All Metrics
Book Value / Share (Quarterly)$2.71
P/TBV (Annual)5.75x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)106.41%
Cash Flow / Share (Quarterly)$-0.35
Price vs S&P 500 (YTD)-6.76%
Gross Margin (TTM)60.34%
Net Profit Margin (TTM)-28.85%
EPS (TTM)$-0.81
10-Day Avg Trading Volume2.10M
EPS Excl Extra (TTM)$-0.81
Revenue Growth (5Y)68.83%
EPS (Annual)$-0.81
ROI (Annual)-20.96%
Gross Margin (Annual)60.34%
Net Profit Margin (5Y Avg)-241.38%
Cash / Share (Quarterly)$2.56
Revenue Growth QoQ (YoY)64.32%
ROA (Last FY)-17.12%
Revenue Growth TTM (YoY)64.04%
EBITD / Share (TTM)$-0.28
ROE (5Y Avg)-40.14%
Operating Margin (TTM)-13.27%
Cash Flow / Share (Annual)$-0.35
P/B Ratio3.91x
P/B Ratio (Quarterly)3.97x
Net Income / Employee (Annual)$-0
EV / Revenue (TTM)3.33x
Net Interest Coverage (TTM)-0.88x
ROA (TTM)-17.58%
EPS Incl Extra (Annual)$-0.81
Current Ratio (Annual)1.96x
Quick Ratio (Quarterly)1.89x
3-Month Avg Trading Volume2.28M
52-Week Price Return-36.73%
Revenue / Employee (TTM)$0
Tangible BV / Share (Quarterly)$2.80
P/S Ratio (Annual)3.81x
Asset Turnover (Annual)0.59x
52-Week High$45.30
Operating Margin (5Y Avg)-242.40%
EPS Excl Extra (Annual)$-0.81
CapEx CAGR (5Y)-10.50%
Tangible BV CAGR (5Y)127.48%
26-Week Price Return-33.22%
Quick Ratio (Annual)1.89x
13-Week Price Return-9.06%
Total Debt / Equity (Annual)0.41x
Current Ratio (Quarterly)1.96x
Enterprise Value$3,427.047
Revenue / Share Growth (5Y)54.47%
Asset Turnover (TTM)0.61x
Book Value / Share Growth (5Y)116.84%
Revenue / Employee (Annual)$0
Inventory Turnover (Annual)14.60x
Pretax Margin (Annual)-27.47%
Cash / Share (Annual)$2.56
3-Month Return Std Dev57.22%
Net Income / Employee (TTM)$-0
ROE (Last FY)-29.62%
Net Interest Coverage (Annual)-0.58x
EPS Basic Excl Extra (Annual)$-0.81
Receivables Turnover (TTM)106.15x
Total Debt / Equity (Quarterly)0.41x
EPS Incl Extra (TTM)$-0.81
Receivables Turnover (Annual)106.14x
ROI (TTM)-21.04%
P/S Ratio (TTM)3.81x
Pretax Margin (5Y Avg)-241.58%
Revenue / Share (Annual)$2.79
Tangible BV / Share (Annual)$2.83
Forward P/E103.66x
Price vs S&P 500 (52W)-71.83%
Year-to-Date Return-2.62%
5-Day Price Return19.67%
EPS Normalized (Annual)$-0.81
ROA (5Y Avg)-25.07%
Net Profit Margin (Annual)-28.85%
Month-to-Date Return17.03%
EBITD / Share (Annual)$-0.28
Operating Margin (Annual)-13.27%
LT Debt / Equity (Annual)0.29x
ROI (5Y Avg)-31.05%
LT Debt / Equity (Quarterly)0.17x
EPS Basic Excl Extra (TTM)$-0.81
P/TBV (Quarterly)6.34x
P/B Ratio (Annual)3.97x
Inventory Turnover (TTM)14.57x
Pretax Margin (TTM)-27.47%
Book Value / Share (Annual)$2.71
Price vs S&P 500 (13W)-11.93%
Beta0.19x
P/FCF (Annual)13.66x
Revenue / Share (TTM)$2.78
ROE (TTM)-29.19%
52-Week Low$16.24
Industry Peers — Pharmaceuticals(308)
| Symbol | P/S Ratio (TTM) | Revenue Growth TTM (YoY) | Gross Margin (TTM) | EPS Growth (5Y) | Price |
|---|---|---|---|---|---|
LEGNLegend Biotech Corporation American Depositary Shares | 3.81x | 64.04% | 60.34% | — | $25.07 |
LLYEli Lilly & Co. | 13.45x | 44.70% | 83.04% | 27.59% | $919.90 |
JNJJohnson & Johnson | 5.82x | 7.87% | 67.95% | 14.90% | $230.69 |
ABBVABBVIE INC. | 5.97x | 8.57% | 71.62% | -2.88% | $203.71 |
MRKMerck & Co., Inc. | 4.51x | 1.31% | 78.55% | 21.23% | $117.10 |
AZNAstraZeneca PLC | 5.39x | 8.63% | 81.31% | 21.88% | $200.69 |
NVSNovartis AG | 4.87x | 8.91% | 75.82% | 15.26% | $150.99 |
NVONovo-Nordisk A/S | 3.74x | 6.43% | 80.98% | 20.66% | $40.46 |
ABTAbbott Laboratories | 3.71x | 6.59% | 56.50% | 8.20% | $96.00 |
PFEPfizer Inc. | 2.50x | -1.64% | 75.81% | -3.51% | $27.52 |
BMYBristol-Myers Squibb Co. | 2.52x | -0.22% | 72.63% | — | $59.13 |
About
Legend Biotech is a biopharmaceutical company developing cell therapies for cancer treatment. Its lead program, LCAR-B38M/JNJ-4528, is a CAR-T therapy in development for multiple myeloma. The company generates revenue through licensing and collaboration agreements, primarily with US partners.